Stockscreener 앱 받기
7.495
0.74%
0.055
시간 외 거래:
7.46
-0.035
-0.47%
전일 마감가:
$7.44
열려 있는:
$7.5
하루 거래량:
192.52K
Relative Volume:
0.77
시가총액:
$276.02M
수익:
$128.45M
순이익/손실:
$6.54M
주가수익비율:
-2.2575
EPS:
-3.32
순현금흐름:
$-8.79M
1주 성능:
+0.20%
1개월 성능:
+36.40%
6개월 성능:
+33.36%
1년 성능:
+2.95%
1일 변동 폭
$7.46
$7.74
1주일 범위
$6.83
$7.99
52주 변동 폭
$3.6793
$8.90
Lifecore Biomedical Inc Stock (LFCR) Company Profile
명칭
Lifecore Biomedical Inc
전화
(952) 368-4300
주소
3515 LYMAN BOULEVARD, CHASKA
LFCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.495 | 276.02M | 128.45M | 6.54M | -8.79M | -3.32 |
|
ZTS
Zoetis Inc
|
176.74 | 79.74B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 43.95B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 43.02B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.78B | 15.05B | -883.30M | 1.89B | 1.53 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-05 | 개시 | Craig Hallum | Buy |
| 2024-08-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Lifecore extends credit terms, simplifies interest rates By Investing.com - Investing.com Canada
Lifecore extends credit terms, simplifies interest rates - Investing.com India
Lifecore Biomedical Strengthens Financial Position with Key Moves - TipRanks
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO - GlobeNewswire
Lifecore Biomedical Extends Credit Facility to 2027, Secures $24.3M Financing | LFCR Stock News - StockTitan
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Soars 36% But It's A Story Of Risk Vs Reward - Simply Wall St
Lifecore Biomedical (NASDAQ:LFCR) Price Target Raised to $10.00 - Defense World
Lifecore Biomedical (NASDAQ:LFCR) Price Target Raised to $10.00 at Craig Hallum - MarketBeat
Lifecore Biomedical shares target upgraded, keeps buy on growth prospects By Investing.com - Investing.com UK
Earnings call: Lifecore Biomedical Q1 fiscal 2025 shows steady growth - Investing.com
Lifecore Biomedical Hosts Virtual Investor Day - The Manila Times
Earnings call: Lifecore Biomedical Q1 Fiscal 2025 highlights growth strategy - Investing.com
Earnings call: Lifecore Biomedical Q1 Fiscal 2025 highlights growth strategy By Investing.com - Investing.com Canada
Lifecore Biomedical Plans Strategic Growth and Transformation - TipRanks
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus.com
Trend Tracker for (LFCR) - Stock Traders Daily
Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR) - Insider Monkey
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) biggest owners are individual investors who got richer after stock soared 14% last week - Simply Wall St
Lifecore Biomedical to Present at Stephens Annual Investment Conference - The Manila Times
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge funds - Yahoo Finance
Lifecore Biomedical: Finally A 'Pure Play' CDMO Business - Seeking Alpha
Lifecore to host virtual investor day on November 21 - Nasdaq
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024 - The Manila Times
Lifecore Biomedical (LFCR) to Host Virtual Investor Day: Growth Strategy Unveiling | LFCR Stock News - StockTitan
Lifecore Biomedical (NASDAQ:LFCR) Trading Up 4.5%Time to Buy? - MarketBeat
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations - GlobeNewswire
Lifecore Biomedical Makes Leadership Appointments - Contract Pharma
Chaska’s Lifecore looks to growth in coming years after emerging from delisting challenge - Star Tribune
How To Trade (LFCR) - Stock Traders Daily
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer - Benzinga
Hyaluronic Acid (HA) Raw Material Market Size And Forecast -Salix Pharmaceuticals, ALLERGAN, Lifecore Biomedical, LLC, S – IndiaPolitics.com - IndiaPolitics.com
Johnson Fistel LLP Investigates Lifecore Biomedical, Inc’s - GlobeNewswire
Q3 2025 Earnings Forecast for Lifecore Biomedical, Inc. Issued By Barrington Research (NASDAQ:LFCR) - MarketBeat
Brokers Set Expectations for Lifecore Biomedical, Inc.'s Q1 2026 Earnings (NASDAQ:LFCR) - MarketBeat
Wynnefield entities buy $1.2m of Lifecore Biomedical stock By Investing.com - Investing.com South Africa
Legion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical Inc - GuruFocus.com
Wynnefield Partners Small Cap Acquires 122,930 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock - MarketBeat
Wynnefield entities buy $1.2m of Lifecore Biomedical stock - Investing.com
Lifecore Biomedical stock price target increased on growth prospects By Investing.com - Investing.com UK
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results By Investing.com - Investing.com Australia
Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results - Investing.com India
Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ... By GuruFocus - Investing.com Canada
Q1 2025 Lifecore Biomedical Inc Earnings Call Transcript - Stockxpo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Marshall Wace LLP - MarketBeat
exhibit991-lfcrq1fy25ear.htm - SEC.gov
Lifecore Biomedical: Fiscal Q1 Earnings Snapshot - mySA
Lifecore Biomedical completes $24.3M private stock sale - Investing.com
Lifecore Biomedical Inc (LFCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.83%
1.03%
자본화:
|
볼륨(24시간):